🎧 Listen to this article

If you coach, train, or advise people on their health in any capacity, the math is straightforward: 10 to 15 percent of adults worldwide have IBS. If you have ten clients, at least one is dealing with bloating, cramping, and unpredictable digestion — and they probably haven’t told you. Many have been dismissed by doctors, told their tests are normal, or learned to manage it in silence. The research on IBS has shifted dramatically in the last five years. It’s no longer a vague diagnosis of exclusion. It’s a condition with measurable mechanisms, distinct subtypes, and specific interventions that actually work.

We’ve covered the gut-brain research and what IBS actually involves at the microbiome level. This post is for the person helping someone with IBS — the coach, the trainer, the nutritionist who needs to know what’s real, what’s noise, and where their scope ends.

IBS isn’t one condition

The first thing to understand: IBS has subtypes, and they respond to different interventions.

IBS-D (diarrhea-predominant) involves increased gut motility and often elevated bile acid production. IBS-C (constipation-predominant) involves slowed motility and altered serotonin signaling in the gut. IBS-M (mixed) alternates between both. A 2023 study in Gut Microbes found that each subtype has a distinct gut microbiome signature — meaning the bacterial imbalance driving IBS-D is fundamentally different from the one driving IBS-C (Su et al., Gut Microbes, 2023).

This matters for coaching because generic advice like “eat more fiber” or “try a probiotic” can help one subtype and make another worse. Soluble fiber often helps IBS-C but can worsen bloating in IBS-D. A high-fiber diet that’s therapeutic for one client might be debilitating for another.

The inflammation connection most people miss

IBS was long considered a functional disorder — meaning no visible inflammation, no structural damage. That view is changing. A 2025 review in the Journal of Gastroenterology found that duodenal eosinophils and mast cells — immune cells involved in inflammatory responses — are elevated in many IBS patients (Talley et al., J Gastroenterol, 2025). This low-grade immune activation doesn’t show up on standard blood work or colonoscopy, but it’s real and it drives symptoms.

What’s feeding that inflammation? The gut microbiome. A large cohort study in Gut showed that long-term dietary patterns are associated with pro-inflammatory and anti-inflammatory features of the gut microbiome (Bolte et al., Gut, 2021). The processed-food-heavy diet many people default to isn’t just “unhealthy” — it’s actively shifting gut bacteria toward a state that makes IBS worse.

The gut-brain axis adds another layer. A 2023 review in Gut Microbes documented how low-level gut inflammation disrupts communication between the intestines and the brain (Yuan et al., Gut Microbes, 2023). This is why IBS clients often report anxiety, brain fog, or fatigue alongside digestive symptoms. Their gut is sending distress signals that affect cognition and mood.

How to recognize IBS in a client who hasn’t told you

Many people with IBS don’t self-identify. They’ve normalized their symptoms or been told “it’s just stress.” Watch for these patterns:

Food avoidance without a clear reason. A client who avoids an expanding list of foods — dairy, gluten, garlic, onion, cruciferous vegetables — without a diagnosed allergy may be self-managing IBS triggers.

Schedule rigidity around meals. If someone insists on eating at exact times or won’t eat before certain activities, they may be managing unpredictable bowel urgency.

Energy crashes after eating. Post-meal fatigue that’s disproportionate to the meal’s size can indicate gut-driven inflammation or altered gut motility.

Anxiety that correlates with digestive symptoms. The gut-brain axis is bidirectional. If a client’s anxiety spikes when their digestion is off, IBS may be the common driver.

Unexplained bloating that worsens through the day. Progressive bloating that’s minimal in the morning and severe by evening is a hallmark pattern.

What the research supports — and what it doesn’t

Low FODMAP diet: effective but temporary. A 2022 network meta-analysis in Gut confirmed the low FODMAP diet’s efficacy across IBS subtypes (Black et al., Gut, 2022). But it’s a diagnostic tool, not a permanent diet. The elimination phase runs 2 to 6 weeks, followed by systematic reintroduction to identify specific triggers. Staying on a permanent low FODMAP diet reduces gut diversity — the opposite of long-term goals (Bertin et al., Nutrients, 2024).

Targeted probiotics: strain matters. Generic probiotics often do nothing for IBS because the wrong strains are in the capsule. Bifidobacterium infantis 35624 and Lactobacillus plantarum 299v have IBS-specific clinical data. If a client is taking a random probiotic and seeing no change, the strain is probably wrong for their subtype.

Garden of Life Probiotics Mood+ — contains L. helveticus and B. longum strains with research supporting the gut-brain axis connection.

Women’s Probiotic — supports gut microbiome diversity and estrogen metabolism, relevant for women whose IBS flares with hormonal shifts.

Stress management: not optional. The brain-gut axis means stress directly changes gut motility, permeability, and microbial composition. Gut-directed hypnotherapy has clinical trial data for IBS. Moderate exercise helps. Not because stress “causes” IBS — but because stress amplifies whatever is already broken.

Fiber: type matters more than amount. Soluble fiber (psyllium, oats, cooked carrots) tends to help. Insoluble fiber (raw vegetables, wheat bran, nuts) can worsen symptoms in IBS-D. Generic “eat more fiber” advice can backfire.

When to refer out

Your scope as a coach has limits. Refer to a gastroenterologist when:

  • Blood in stool — always a red flag, never IBS alone
  • Unintentional weight loss — suggests malabsorption or something beyond IBS
  • Symptoms starting after 50 — higher risk for other conditions
  • Nighttime symptoms that wake them — IBS typically improves at night; if it doesn’t, investigate further
  • Family history of inflammatory bowel disease or colorectal cancer — genetic risk changes the diagnostic urgency
  • Progressive worsening despite intervention — if dietary changes and stress management aren’t moving the needle after 8–12 weeks, medical evaluation is needed

What to stop telling IBS clients

“Just eat clean.” This is meaningless advice for someone with a specific microbial imbalance. “Clean” foods like garlic, onion, and cruciferous vegetables are high FODMAP and can trigger severe symptoms in sensitive individuals.

“It’s probably just stress.” Even if stress is a factor, dismissing the physiological reality of IBS undermines trust. The inflammation is real. The microbiome disruption is real. Stress amplifies it — it doesn’t invent it.

“Try this supplement.” Without knowing the subtype and specific triggers, supplement recommendations are guesswork. A probiotic that helps IBS-C can worsen IBS-D.

What we still don’t know

The biggest gap in IBS research is personalized intervention. We know the subtypes exist. We know the microbiome signatures differ. What we don’t yet have is a reliable way to match a specific client to the exact intervention that will work for them — beyond trial and error. The low FODMAP diet works for many, but not all. Targeted probiotics help some, not others. The research is moving toward microbiome-based precision nutrition, but we’re not there yet.

What we do know: IBS is real, it’s measurable, and the dismissive “it’s just in your head” era is over. If you work with people, you work with IBS. Understanding the mechanisms — and knowing when you’ve hit the edge of your scope — is the difference between helping and accidentally making things worse.

If you coach or train people, someone in your circle needs to hear this.